Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 1259

    1.

    Novel therapies in the treatment of multiple myeloma.

    Laubach JP, Mitsiades CS, Mahindra A, Schlossman RL, Hideshima T, Chauhan D, Carreau NA, Ghobrial IM, Raje N, Munshi NC, Anderson KC, Richardson PG.

    J Natl Compr Canc Netw. 2009 Oct;7(9):947-60.PMID: 19878638 [PubMed - in process]Related articles

    2.

    Europium complexes with high total photoluminescence quantum yields in solution and in PMMA.

    Moudam O, Rowan BC, Alamiry M, Richardson P, Richards BS, Jones AC, Robertson N.

    Chem Commun (Camb). 2009 Nov 21;(43):6649-51. Epub 2009 Sep 25.PMID: 19865679 [PubMed - in process]Related articles

    3.

    How I treat multiple myeloma in younger patients.

    Stewart AK, Richardson PG, San-Miguel JF.

    Blood. 2009 Oct 27. [Epub ahead of print]PMID: 19861683 [PubMed - as supplied by publisher]Related articles

    4.

    VMP (Bortezomib, Melphalan, and Prednisone) Is Active and Well Tolerated in Newly Diagnosed Patients With Multiple Myeloma With Moderately Impaired Renal Function, and Results in Reversal of Renal Impairment: Cohort Analysis of the Phase III VISTA Study.

    Dimopoulos MA, Richardson PG, Schlag R, Khuageva NK, Shpilberg O, Kastritis E, Kropff M, Petrucci MT, Delforge M, Alexeeva J, Schots R, Masszi T, Mateos MV, Deraedt W, Liu K, Cakana A, van de Velde H, San Miguel JF.

    J Clin Oncol. 2009 Oct 26. [Epub ahead of print]PMID: 19858394 [PubMed - as supplied by publisher]Related articles

    5.

    Neuroscience. Nuclear power for axonal growth.

    Subang MC, Richardson PM.

    Science. 2009 Oct 9;326(5950):238-9. No abstract available. PMID: 19815761 [PubMed - indexed for MEDLINE]Related articles

    6.

    The fibrinolytic mechanism of defibrotide: effect of defibrotide on plasmin activity.

    Echart CL, Graziadio B, Somaini S, Ferro LI, Richardson PG, Fareed J, Iacobelli M.

    Blood Coagul Fibrinolysis. 2009 Oct 3. [Epub ahead of print]PMID: 19809307 [PubMed - as supplied by publisher]Related articles

    7.

    Functional interaction of plasmacytoid dendritic cells with multiple myeloma cells: a therapeutic target.

    Chauhan D, Singh AV, Brahmandam M, Carrasco R, Bandi M, Hideshima T, Bianchi G, Podar K, Tai YT, Mitsiades C, Raje N, Jaye DL, Kumar SK, Richardson P, Munshi N, Anderson KC.

    Cancer Cell. 2009 Oct 6;16(4):309-23.PMID: 19800576 [PubMed - indexed for MEDLINE]Related articles

    8.

    Hematology: Thalidomide maintenance in multiple myeloma.

    Laubach JP, Richardson PG, Anderson KC.

    Nat Rev Clin Oncol. 2009 Oct;6(10):565-6. No abstract available. PMID: 19787000 [PubMed - in process]Related articles

    9.

    Multicenter, Phase I, Dose-Escalation Trial of Lenalidomide Plus Bortezomib for Relapsed and Relapsed/Refractory Multiple Myeloma.

    Richardson PG, Weller E, Jagannath S, Avigan DE, Alsina M, Schlossman RL, Mazumder A, Munshi NC, Ghobrial IM, Doss D, Warren DL, Lunde LE, McKenney M, Delaney C, Mitsiades CS, Hideshima T, Dalton W, Knight R, Esseltine DL, Anderson KC.

    J Clin Oncol. 2009 Nov 9. [Epub ahead of print]PMID: 19786667 [PubMed - as supplied by publisher]Related articles

    10.

    Hepatic Veno-occlusive Disease following Stem Cell Transplantation: Incidence, Clinical Course and Outcome.

    Coppell JA, Richardson PG, Soiffer R, Martin PL, Kernan NA, Chen A, Guinan E, Vogelsang G, Krishnan A, Giralt S, Revta C, Carreau NA, Iacobelli M, Carreras E, Ruutu T, Barbui T, Antin JH, Niederwieser D.

    Biol Blood Marrow Transplant. 2009 Sep 17. [Epub ahead of print]PMID: 19766729 [PubMed - as supplied by publisher]Related articles

    11.

    In vitro anti-myeloma activity of the Aurora kinase inhibitor VE-465.

    Negri JM, McMillin DW, Delmore J, Mitsiades N, Hayden P, Klippel S, Hideshima T, Chauhan D, Munshi NC, Buser CA, Pollard J, Richardson PG, Anderson KC, Mitsiades CS.

    Br J Haematol. 2009 Dec;147(5):672-6. Epub 2009 Sep 14.PMID: 19751238 [PubMed - in process]Related articles

    12.

    Impact of High-Dose Chemotherapy on the Ability to Deliver Subsequent Local-Regional Radiotherapy for Breast Cancer: Analysis of Cancer and Leukemia Group B Protocol 9082.

    Marks LB, Cirrincione C, Fitzgerald TJ, Laurie F, Glicksman AS, Vredenburgh J, Prosnitz LR, Shpall EJ, Crump M, Richardson PG, Schuster MW, Ma J, Peterson BL, Norton L, Seagren S, Craig Henderson I, Hurd DD, Peters WP; for the Cancer and Leukemia Group B, Southwest Oncology Group, and National Cancer Institute of Canada Clinical Trials Group.

    Int J Radiat Oncol Biol Phys. 2009 Sep 9. [Epub ahead of print]PMID: 19747781 [PubMed - as supplied by publisher]Related articles

    13.

    The use of novel agents in the treatment of relapsed and refractory multiple myeloma.

    Laubach JP, Mahindra A, Mitsiades CS, Schlossman RL, Munshi NC, Ghobrial IM, Carreau N, Hideshima T, Anderson KC, Richardson PG.

    Leukemia. 2009 Sep 10. [Epub ahead of print]PMID: 19741729 [PubMed - as supplied by publisher]Related articles

    14.

    Evaluation of novel particles as an inhalation system for GLP-1.

    Leone-Bay A, Grant M, Greene S, Stowell G, Daniels S, Smithson A, Villanueva S, Cope S, Carrera K, Reyes S, Richardson P.

    Diabetes Obes Metab. 2009 Nov;11(11):1050-9. Epub 2009 Sep 3.PMID: 19732123 [PubMed - in process]Related articles

    15.

    Impact of prior therapies on the relative efficacy of bortezomib compared with dexamethasone in patients with relapsed/refractory multiple myeloma.

    Vogl DT, Stadtmauer EA, Richardson PG, Sonneveld P, Schuster MW, Irwin D, Facon T, Harousseau JL, Boral A, Neuwirth R, Anderson KC.

    Br J Haematol. 2009 Nov;147(4):531-4. Epub 2009 Sep 1.PMID: 19725827 [PubMed - in process]Related articles

    16.

    Advances in the treatment of monoclonal gammopaties: The emerging role of targeted therapy in plasma cell dyscrasias.

    Roccaro AM, Ghobrial IM, Blotta S, Treon SP, Malagola M, Anderson KC, Richardson PG, Russo D.

    Biologics. 2008 Sep;2(3):419-31.PMID: 19707373 [PubMed - in process]Related articlesFree article

    17.

    Caesarean delivery in a parturient with a femoro-femoral crossover graft and congenital aortic stenosis repaired by the Ross procedure.

    Richardson P, Whittaker S, Rajesh U, Bonduelle M, Morgan J, Garry M, Weston C, Ferguson C, Fligelstone L.

    Int J Obstet Anesth. 2009 Oct;18(4):387-91. Epub 2009 Aug 22.PMID: 19703763 [PubMed - in process]Related articles

    18.

    The TFS mini-sling for uterine/vault prolapse repair: a three-year follow-up review.

    Petros PE, Richardson PA.

    Aust N Z J Obstet Gynaecol. 2009 Aug;49(4):439-40.PMID: 19694704 [PubMed - indexed for MEDLINE]Related articles

    19.

    Neuronal correlates and serotonergic modulation of behavioural inhibition and reward in healthy and antisocial individuals.

    Völlm B, Richardson P, McKie S, Reniers R, Elliott R, Anderson IM, Williams S, Dolan M, Deakin B.

    J Psychiatr Res. 2009 Aug 13. [Epub ahead of print]PMID: 19683258 [PubMed - as supplied by publisher]Related articles

    20.

    Reduced CD38 expression on CD34+ cells as a diagnostic test in myelodysplastic syndromes.

    Goardon N, Nikolousis E, Sternberg A, Chu WK, Craddock C, Richardson P, Benson R, Drayson M, Standen G, Vyas P, Freeman S.

    Haematologica. 2009 Aug;94(8):1160-3.PMID: 19644143 [PubMed - in process]Related articlesFree article

    21.

    Targeting a Dominant Negative Rho Kinase to Neurons Promotes Axonal Outgrowth and Partial Functional Recovery After Rat Rubrospinal Tract Lesion.

    Wu D, Yang P, Zhang X, Luo J, Haque ME, Yeh J, Richardson PM, Zhang Y, Bo X.

    Mol Ther. 2009 Jul 21. [Epub ahead of print]PMID: 19623163 [PubMed - as supplied by publisher]Related articles

    22.

    A gastrointestinal cause for heart failure.

    Aravinthan A, Al-Naeeb Y, Abubacker Z, Richardson P.

    Gut. 2009 Aug;58(8):1103, 1128. No abstract available. PMID: 19592694 [PubMed - indexed for MEDLINE]Related articles

    23.

    Antimyeloma activity of the orally bioavailable dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235.

    McMillin DW, Ooi M, Delmore J, Negri J, Hayden P, Mitsiades N, Jakubikova J, Maira SM, Garcia-Echeverria C, Schlossman R, Munshi NC, Richardson PG, Anderson KC, Mitsiades CS.

    Cancer Res. 2009 Jul 15;69(14):5835-42. Epub 2009 Jul 7.PMID: 19584292 [PubMed - indexed for MEDLINE]Related articles

    24.

    Thorotrast-induced primary cerebral angiosarcoma: case report.

    Balamurali G, du Plessis DG, Wengoy M, Bryan N, Herwadkar A, Richardson PL.

    Neurosurgery. 2009 Jul;65(1):E210-1; discussion E211.PMID: 19574803 [PubMed - indexed for MEDLINE]Related articles

    25.

    Therapeutic intent of proton pump inhibitor prescription among elderly nonsteroidal anti-inflammatory drug users.

    Dries AM, Richardson P, Cavazos J, Abraham NS.

    Aliment Pharmacol Ther. 2009 Sep 15;30(6):652-61. Epub 2009 Jul 2.PMID: 19573167 [PubMed - in process]Related articles

    26.

    The extent and determinants of prescribing and adherence with acid-reducing medications: a national claims database study.

    El-Serag HB, Fitzgerald S, Richardson P.

    Am J Gastroenterol. 2009 Sep;104(9):2161-7. Epub 2009 Jun 30.PMID: 19568229 [PubMed - indexed for MEDLINE]Related articles

    27.

    Mobilization in myeloma revisited: IMWG consensus perspectives on stem cell collection following initial therapy with thalidomide-, lenalidomide-, or bortezomib-containing regimens.

    Kumar S, Giralt S, Stadtmauer EA, Harousseau JL, Palumbo A, Bensinger W, Comenzo RL, Lentzsch S, Munshi N, Niesvizky R, San Miguel J, Ludwig H, Bergsagel L, Blade J, Lonial S, Anderson KC, Tosi P, Sonneveld P, Sezer O, Vesole D, Cavo M, Einsele H, Richardson PG, Durie BG, Rajkumar SV; International Myeloma Working Group.

    Blood. 2009 Aug 27;114(9):1729-35. Epub 2009 Jun 26.PMID: 19561323 [PubMed - indexed for MEDLINE]Related articles

    28.

    International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100).

    Giralt S, Stadtmauer EA, Harousseau JL, Palumbo A, Bensinger W, Comenzo RL, Kumar S, Munshi NC, Dispenzieri A, Kyle R, Merlini G, San Miguel J, Ludwig H, Hajek R, Jagannath S, Blade J, Lonial S, Dimopoulos MA, Einsele H, Barlogie B, Anderson KC, Gertz M, Attal M, Tosi P, Sonneveld P, Boccadoro M, Morgan G, Sezer O, Mateos MV, Cavo M, Joshua D, Turesson I, Chen W, Shimizu K, Powles R, Richardson PG, Niesvizky R, Rajkumar SV, Durie BG; IMWG.

    Leukemia. 2009 Oct;23(10):1904-12. Epub 2009 Jun 25.PMID: 19554029 [PubMed - indexed for MEDLINE]Related articles

    29.

    Expanded safety experience with lenalidomide plus dexamethasone in relapsed or refractory multiple myeloma.

    Chen C, Reece DE, Siegel D, Niesvizky R, Boccia RV, Stadtmauer EA, Abonour R, Richardson P, Matous J, Kumar S, Bahlis NJ, Alsina M, Vescio R, Coutre SE, Pietronigro D, Knight RD, Zeldis JB, Rajkumar V.

    Br J Haematol. 2009 Jul;146(2):164-70. Epub 2009 May 26.PMID: 19545290 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    Multiple myeloma.

    Raab MS, Podar K, Breitkreutz I, Richardson PG, Anderson KC.

    Lancet. 2009 Jul 25;374(9686):324-39. Epub 2009 Jun 21. Review.PMID: 19541364 [PubMed - indexed for MEDLINE]Related articles

    31.

    Single-agent bortezomib in previously untreated multiple myeloma: efficacy, characterization of peripheral neuropathy, and molecular correlations with response and neuropathy.

    Richardson PG, Xie W, Mitsiades C, Chanan-Khan AA, Lonial S, Hassoun H, Avigan DE, Oaklander AL, Kuter DJ, Wen PY, Kesari S, Briemberg HR, Schlossman RL, Munshi NC, Heffner LT, Doss D, Esseltine DL, Weller E, Anderson KC, Amato AA.

    J Clin Oncol. 2009 Jul 20;27(21):3518-25. Epub 2009 Jun 15.PMID: 19528374 [PubMed - indexed for MEDLINE]Related articles

    32.

    The monoclonal antibody nBT062 conjugated to cytotoxic Maytansinoids has selective cytotoxicity against CD138-positive multiple myeloma cells in vitro and in vivo.

    Ikeda H, Hideshima T, Fulciniti M, Lutz RJ, Yasui H, Okawa Y, Kiziltepe T, Vallet S, Pozzi S, Santo L, Perrone G, Tai YT, Cirstea D, Raje NS, Uherek C, Dälken B, Aigner S, Osterroth F, Munshi N, Richardson P, Anderson KC.

    Clin Cancer Res. 2009 Jun 15;15(12):4028-37. Epub 2009 Jun 9.PMID: 19509164 [PubMed - indexed for MEDLINE]Related articles

    33.

    The management of pain in the burns unit.

    Richardson P, Mustard L.

    Burns. 2009 Nov;35(7):921-36. Epub 2009 Jun 7.PMID: 19505764 [PubMed - in process]Related articles

    34.

    International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation.

    Palumbo A, Sezer O, Kyle R, Miguel JS, Orlowski RZ, Moreau P, Niesvizky R, Morgan G, Comenzo R, Sonneveld P, Kumar S, Hajek R, Giralt S, Bringhen S, Anderson KC, Richardson PG, Cavo M, Davies F, Bladé J, Einsele H, Dimopoulos MA, Spencer A, Dispenzieri A, Reiman T, Shimizu K, Lee JH, Attal M, Boccadoro M, Mateos M, Chen W, Ludwig H, Joshua D, Chim J, Hungria V, Turesson I, Durie BG, Lonial S; IMWG.

    Leukemia. 2009 Oct;23(10):1716-30. Epub 2009 Jun 4. Review.PMID: 19494840 [PubMed - indexed for MEDLINE]Related articles

    35.

    Maximizing the clinical benefit of novel therapies in multiple myeloma.

    Laubach J, Mitsiades C, Anderson K, Richardson P.

    Oncology (Williston Park). 2009 Apr 30;23(5):415-6, 419. Review. No abstract available. PMID: 19476274 [PubMed - indexed for MEDLINE]Related articles

    36.

    Safety and efficacy of single-agent lenalidomide in patients with relapsed and refractory multiple myeloma.

    Richardson P, Jagannath S, Hussein M, Berenson J, Singhal S, Irwin D, Williams SF, Bensinger W, Badros AZ, Vescio R, Kenvin L, Yu Z, Olesnyckyj M, Zeldis J, Knight R, Anderson KC.

    Blood. 2009 Jul 23;114(4):772-8. Epub 2009 May 26.PMID: 19471019 [PubMed - indexed for MEDLINE]Related articles

    37.

    Clinical challenges associated with bortezomib therapy in multiple myeloma and Waldenströms Macroglobulinemia.

    Laubach JP, Mitsiades CS, Roccaro AM, Ghobrial IM, Anderson KC, Richardson PG.

    Leuk Lymphoma. 2009 May;50(5):694-702. Review. Erratum in: Leuk Lymphoma. 2009 Jul;50(7):1235. PMID: 19452315 [PubMed - indexed for MEDLINE]Related articles

    38.

    Bortezomib induces canonical nuclear factor-kappaB activation in multiple myeloma cells.

    Hideshima T, Ikeda H, Chauhan D, Okawa Y, Raje N, Podar K, Mitsiades C, Munshi NC, Richardson PG, Carrasco RD, Anderson KC.

    Blood. 2009 Jul 30;114(5):1046-52. Epub 2009 May 12.PMID: 19436050 [PubMed - indexed for MEDLINE]Related articles

    39.

    Zoosporic tolerance to pH stress and its implications for Phytophthora species in aquatic ecosystems.

    Kong P, Moorman GW, Lea-Cox JD, Ross DS, Richardson PA, Hong C.

    Appl Environ Microbiol. 2009 Jul;75(13):4307-14. Epub 2009 May 8.PMID: 19429548 [PubMed - indexed for MEDLINE]Related articles

    40.

    Emerging treatments for multiple myeloma: beyond immunomodulatory drugs and bortezomib.

    Mitsiades CS, Hideshima T, Chauhan D, McMillin DW, Klippel S, Laubach JP, Munshi NC, Anderson KC, Richardson PG.

    Semin Hematol. 2009 Apr;46(2):166-75. Review.PMID: 19389500 [PubMed - indexed for MEDLINE]Related articles

    41.

    Relative adrenal insufficiency in a patient with liver disease.

    Aravinthan A, Al-Naeeb Y, Richardson P.

    Eur J Gastroenterol Hepatol. 2009 Apr;21(4):471-3.PMID: 19382344 [PubMed - in process]Related articles

    42.

    Effect of red blood cells on platelet aggregation.

    Pivkin I, Richardson P, Karniadakis G.

    IEEE Eng Med Biol Mag. 2009 Mar-Apr;28(2):32-7.PMID: 19349249 [PubMed - indexed for MEDLINE]Related articles

    43.

    Crystal structure and thermodynamic analysis of diagnostic mAb 106.3 complexed with BNP 5-13 (C10A).

    Longenecker KL, Ruan Q, Fry EH, Saldana SC, Brophy SE, Richardson PL, Tetin SY.

    Proteins. 2009 Aug 15;76(3):536-47.PMID: 19274732 [PubMed - indexed for MEDLINE]Related articles

    44.

    Biologic sequelae of I{kappa}B kinase (IKK) inhibition in multiple myeloma: therapeutic implications.

    Hideshima T, Chauhan D, Kiziltepe T, Ikeda H, Okawa Y, Podar K, Raje N, Protopopov A, Munshi NC, Richardson PG, Carrasco RD, Anderson KC.

    Blood. 2009 May 21;113(21):5228-36. Epub 2009 Mar 6.PMID: 19270264 [PubMed - indexed for MEDLINE]Related articles

    45.

    Hospitalizations for inflammatory bowel disease among US military veterans 1975-2006.

    Sonnenberg A, Richardson PA, Abraham NS.

    Dig Dis Sci. 2009 Aug;54(8):1740-5. Epub 2009 Mar 4.PMID: 19259815 [PubMed - indexed for MEDLINE]Related articles

    46.

    Emerging therapies for multiple myeloma.

    Podar K, Tai YT, Hideshima T, Vallet S, Richardson PG, Anderson KC.

    Expert Opin Emerg Drugs. 2009 Mar;14(1):99-127. Review.PMID: 19249983 [PubMed - indexed for MEDLINE]Related articles

    47.

    Sinus tracts--an early sign of bisphosphonate-associated osteonecrosis of the jaws?

    Mawardi H, Treister N, Richardson P, Anderson K, Munshi N, Faiella RA, Woo SB.

    J Oral Maxillofac Surg. 2009 Mar;67(3):593-601.PMID: 19231786 [PubMed - indexed for MEDLINE]Related articles

    48.

    Preclinical studies in support of defibrotide for the treatment of multiple myeloma and other neoplasias.

    Mitsiades CS, Rouleau C, Echart C, Menon K, Teicher B, Distaso M, Palumbo A, Boccadoro M, Anderson KC, Iacobelli M, Richardson PG.

    Clin Cancer Res. 2009 Feb 15;15(4):1210-21.PMID: 19228727 [PubMed - indexed for MEDLINE]Related articles

    49.

    Structural characterization of a soluble amyloid beta-peptide oligomer.

    Yu L, Edalji R, Harlan JE, Holzman TF, Lopez AP, Labkovsky B, Hillen H, Barghorn S, Ebert U, Richardson PL, Miesbauer L, Solomon L, Bartley D, Walter K, Johnson RW, Hajduk PJ, Olejniczak ET.

    Biochemistry. 2009 Mar 10;48(9):1870-7.PMID: 19216516 [PubMed - indexed for MEDLINE]Related articles

    50.

    A voxel-based morphometric MRI study in men with borderline personality disorder: preliminary findings.

    Völlm BA, Zhao L, Richardson P, Clark L, Deakin JF, Williams S, Dolan MC.

    Crim Behav Ment Health. 2009;19(1):64-72.PMID: 19172640 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...